Stocks and Investing Stocks and Investing
Tue, August 6, 2024
Mon, August 5, 2024

Gena Wang Downgraded (VRTX) to Hold and Increased Target to $509 on, Aug 5th, 2024


Published on 2024-10-28 13:13:15 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Downgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Hold and Increased Target from $472 to $509 on, Aug 5th, 2024.

Gena has made no other calls on VRTX in the last 4 months.



There are 14 other peers that have a rating on VRTX. Out of the 14 peers that are also analyzing VRTX, 3 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joseph Stringer of "Needham" Reiterated at Hold on, Friday, July 26th, 2024
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $455 on, Thursday, July 11th, 2024
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $421 on, Tuesday, June 11th, 2024


These are the ratings of the 11 analyists that currently disagree with Gena


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $535 on, Friday, August 2nd, 2024
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $558 on, Friday, August 2nd, 2024
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $480 on, Friday, August 2nd, 2024
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell with Increased Target to $376 on, Wednesday, July 31st, 2024
  • Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Increased Target to $500 on, Tuesday, July 23rd, 2024
  • Steve Chesney of "Redburn Atlantic" Initiated at Strong Buy and Held Target at $545 on, Thursday, June 27th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $555 on, Monday, June 24th, 2024
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $550 on, Monday, June 17th, 2024
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $500 on, Friday, May 31st, 2024
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $466 on, Wednesday, April 17th, 2024
  • Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $438 on, Thursday, April 11th, 2024
Contributing Sources